Range of Motion Products, LLC v. Armaid Company Inc.

Headline: Federal Circuit Affirms Non-Infringement of Therapeutic Device Patent

Citation:

Court: Federal Circuit · Filed: 2026-02-02 · Docket: 23-2427
Published
This decision reinforces the importance of precise claim drafting and the limitations imposed by means-plus-function claims. It clarifies that even if an accused product performs a similar function, it will not be found to infringe if its underlying structure is not substantially the same as that disclosed in the patent specification. moderate affirmed
Outcome: Defendant Win
Impact Score: 20/100 — Low impact: This case is narrowly focused with minimal precedential value.
Legal Topics: Patent infringementMeans-plus-function claimsClaim construction35 U.S.C. § 112(f)Structural equivalents in patent law
Legal Principles: Doctrine of equivalentsInterpretation of means-plus-function claimsSubstantiality of structural differences

Case Summary

Range of Motion Products, LLC v. Armaid Company Inc., decided by Federal Circuit on February 2, 2026, resulted in a defendant win outcome. The core dispute centered on whether Range of Motion Products (ROM) infringed on Armaid Company's patent for a "device for applying a therapeutic agent to a body part." The Federal Circuit affirmed the district court's finding of non-infringement, holding that ROM's product did not meet the "substantially the same" limitation of the patent's "means-plus-function" claim element. The court found that ROM's device operated differently and lacked the specific structural elements required by the patent. The court held: The court affirmed the district court's finding of non-infringement because the accused product did not infringe the 'means-plus-function' claim element of the patent.. ROM's device did not infringe the patent's claim 1 because it did not include the structure disclosed in the patent specification for performing the function of "applying a therapeutic agent to a body part.". The court found that the accused device's method of operation and structural components were not substantially the same as those disclosed in the patent specification for the 'means-plus-function' element.. The patent's claim 1 recited a "means for applying a therapeutic agent to a body part," which, under 35 U.S.C. § 112(f), must be construed to include the corresponding structure described in the specification and equivalents thereof.. ROM's device, which uses a roller mechanism to apply the agent, was found to be structurally and functionally different from the patent's disclosed structure for applying the agent, which involved a "flexible applicator.". This decision reinforces the importance of precise claim drafting and the limitations imposed by means-plus-function claims. It clarifies that even if an accused product performs a similar function, it will not be found to infringe if its underlying structure is not substantially the same as that disclosed in the patent specification.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Key Holdings

The court established the following key holdings in this case:

  1. The court affirmed the district court's finding of non-infringement because the accused product did not infringe the 'means-plus-function' claim element of the patent.
  2. ROM's device did not infringe the patent's claim 1 because it did not include the structure disclosed in the patent specification for performing the function of "applying a therapeutic agent to a body part."
  3. The court found that the accused device's method of operation and structural components were not substantially the same as those disclosed in the patent specification for the 'means-plus-function' element.
  4. The patent's claim 1 recited a "means for applying a therapeutic agent to a body part," which, under 35 U.S.C. § 112(f), must be construed to include the corresponding structure described in the specification and equivalents thereof.
  5. ROM's device, which uses a roller mechanism to apply the agent, was found to be structurally and functionally different from the patent's disclosed structure for applying the agent, which involved a "flexible applicator."

Deep Legal Analysis

Constitutional Issues

Patent infringementClaim construction

Rule Statements

Claim construction is a matter of law that this court reviews de novo.
The specification is the primary source for understanding the meaning of claim terms.

Remedies

Vacated the district court's grant of summary judgment of non-infringement.Remanded the case for further proceedings consistent with the Federal Circuit's claim construction.

Entities and Participants

Frequently Asked Questions (41)

Comprehensive Q&A covering every aspect of this court opinion.

Basic Questions (9)

Q: What is Range of Motion Products, LLC v. Armaid Company Inc. about?

Range of Motion Products, LLC v. Armaid Company Inc. is a case decided by Federal Circuit on February 2, 2026.

Q: What court decided Range of Motion Products, LLC v. Armaid Company Inc.?

Range of Motion Products, LLC v. Armaid Company Inc. was decided by the Federal Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was Range of Motion Products, LLC v. Armaid Company Inc. decided?

Range of Motion Products, LLC v. Armaid Company Inc. was decided on February 2, 2026.

Q: What is the citation for Range of Motion Products, LLC v. Armaid Company Inc.?

The citation for Range of Motion Products, LLC v. Armaid Company Inc. is . Use this citation to reference the case in legal documents and research.

Q: What is the full case name and what court decided it?

The case is Range of Motion Products, LLC v. Armaid Company Inc., and it was decided by the United States Court of Appeals for the Federal Circuit (CAFC). This court specializes in patent law, making it the appropriate venue for this dispute.

Q: Who were the parties involved in the Range of Motion Products v. Armaid Company Inc. lawsuit?

The parties were Range of Motion Products, LLC (ROM), the alleged infringer, and Armaid Company Inc., the patent holder. Armaid Company Inc. accused ROM of infringing on its patent for a therapeutic agent application device.

Q: What was the central issue in the Range of Motion Products v. Armaid Company Inc. case?

The central issue was whether Range of Motion Products' device infringed on Armaid Company's patent for a 'device for applying a therapeutic agent to a body part.' Specifically, the dispute focused on whether ROM's product met a particular limitation within the patent's claims.

Q: What is a 'device for applying a therapeutic agent to a body part' as described in the patent?

While the opinion doesn't detail the exact mechanism, the patent describes a device designed to deliver therapeutic agents, such as creams or ointments, to a body part. The dispute focused on the specific structural means by which ROM's device achieved this function compared to Armaid's patented structure.

Q: What is the 'nature of the dispute' in Range of Motion Products v. Armaid Company Inc.?

The nature of the dispute was patent infringement. Armaid Company Inc. alleged that Range of Motion Products, LLC's product violated their patent rights by making, using, or selling a device that was covered by their patent claims.

Legal Analysis (15)

Q: Is Range of Motion Products, LLC v. Armaid Company Inc. published?

Range of Motion Products, LLC v. Armaid Company Inc. is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Range of Motion Products, LLC v. Armaid Company Inc.?

The court ruled in favor of the defendant in Range of Motion Products, LLC v. Armaid Company Inc.. Key holdings: The court affirmed the district court's finding of non-infringement because the accused product did not infringe the 'means-plus-function' claim element of the patent.; ROM's device did not infringe the patent's claim 1 because it did not include the structure disclosed in the patent specification for performing the function of "applying a therapeutic agent to a body part."; The court found that the accused device's method of operation and structural components were not substantially the same as those disclosed in the patent specification for the 'means-plus-function' element.; The patent's claim 1 recited a "means for applying a therapeutic agent to a body part," which, under 35 U.S.C. § 112(f), must be construed to include the corresponding structure described in the specification and equivalents thereof.; ROM's device, which uses a roller mechanism to apply the agent, was found to be structurally and functionally different from the patent's disclosed structure for applying the agent, which involved a "flexible applicator.".

Q: Why is Range of Motion Products, LLC v. Armaid Company Inc. important?

Range of Motion Products, LLC v. Armaid Company Inc. has an impact score of 20/100, indicating limited broader impact. This decision reinforces the importance of precise claim drafting and the limitations imposed by means-plus-function claims. It clarifies that even if an accused product performs a similar function, it will not be found to infringe if its underlying structure is not substantially the same as that disclosed in the patent specification.

Q: What precedent does Range of Motion Products, LLC v. Armaid Company Inc. set?

Range of Motion Products, LLC v. Armaid Company Inc. established the following key holdings: (1) The court affirmed the district court's finding of non-infringement because the accused product did not infringe the 'means-plus-function' claim element of the patent. (2) ROM's device did not infringe the patent's claim 1 because it did not include the structure disclosed in the patent specification for performing the function of "applying a therapeutic agent to a body part." (3) The court found that the accused device's method of operation and structural components were not substantially the same as those disclosed in the patent specification for the 'means-plus-function' element. (4) The patent's claim 1 recited a "means for applying a therapeutic agent to a body part," which, under 35 U.S.C. § 112(f), must be construed to include the corresponding structure described in the specification and equivalents thereof. (5) ROM's device, which uses a roller mechanism to apply the agent, was found to be structurally and functionally different from the patent's disclosed structure for applying the agent, which involved a "flexible applicator."

Q: What are the key holdings in Range of Motion Products, LLC v. Armaid Company Inc.?

1. The court affirmed the district court's finding of non-infringement because the accused product did not infringe the 'means-plus-function' claim element of the patent. 2. ROM's device did not infringe the patent's claim 1 because it did not include the structure disclosed in the patent specification for performing the function of "applying a therapeutic agent to a body part." 3. The court found that the accused device's method of operation and structural components were not substantially the same as those disclosed in the patent specification for the 'means-plus-function' element. 4. The patent's claim 1 recited a "means for applying a therapeutic agent to a body part," which, under 35 U.S.C. § 112(f), must be construed to include the corresponding structure described in the specification and equivalents thereof. 5. ROM's device, which uses a roller mechanism to apply the agent, was found to be structurally and functionally different from the patent's disclosed structure for applying the agent, which involved a "flexible applicator."

Q: What cases are related to Range of Motion Products, LLC v. Armaid Company Inc.?

Precedent cases cited or related to Range of Motion Products, LLC v. Armaid Company Inc.: In re Donaldson Co., 16 F.3d 1189 (Fed. Cir. 1994); Enzo Biochem, Inc. v. Applera Corp., 599 F.3d 1325 (Fed. Cir. 2010).

Q: What specific patent claim element was at the heart of the infringement dispute?

The dispute centered on the 'means-plus-function' claim element of Armaid's patent, which required the device to perform a specific function using 'equivalent' structure. The Federal Circuit examined whether ROM's device met the 'substantially the same' structural limitation associated with this element.

Q: What was the Federal Circuit's holding regarding infringement in this case?

The Federal Circuit affirmed the district court's finding of non-infringement. The court concluded that Range of Motion Products' device did not infringe Armaid Company's patent because it did not meet the 'substantially the same' structural requirement of the 'means-plus-function' claim element.

Q: Why did the Federal Circuit find that ROM's product did not meet the 'substantially the same' limitation?

The court found that ROM's device operated differently from the structure disclosed in Armaid's patent and lacked the specific structural elements required by the patent for the claimed function. This difference in operation and structure was key to the non-infringement finding.

Q: What legal standard does the 'means-plus-function' claim element involve?

Under 35 U.S.C. § 112(f), a 'means-plus-function' claim element is interpreted to cover the corresponding structure described in the patent specification and equivalents thereof. The accused device must perform the claimed function using a structure that is substantially the same as or equivalent to the disclosed structure.

Q: Did the court consider the functionality of ROM's device in its infringement analysis?

Yes, while functionality is part of the 'means-plus-function' analysis, the Federal Circuit focused on the structural differences. The court determined that ROM's device, despite potentially performing a similar function, did not employ substantially the same structure as that described in Armaid's patent specification.

Q: What is the significance of the 'equivalent structure' in a means-plus-function claim?

The 'equivalent structure' is crucial because it defines the scope of the patent protection for a means-plus-function claim. An accused product infringes if it uses a structure that is substantially the same as, or equivalent to, the structure disclosed in the patent specification for performing the claimed function.

Q: What does it mean for a patent claim to be 'means-plus-function'?

A 'means-plus-function' claim uses the phrase 'means for' followed by a function, rather than describing a specific structure. Under patent law, such claims are interpreted to cover the corresponding structure disclosed in the patent's specification and its equivalents.

Q: What is the burden of proof in a patent infringement case?

In a patent infringement case, the patent holder (like Armaid Company) bears the burden of proving that the accused product infringes on their patent claims. This burden requires demonstrating that the accused product embodies every element of at least one patent claim.

Q: What specific structural elements were missing or different in ROM's device according to the court?

The opinion does not specify the exact structural elements that were deemed different or missing. However, it indicates that the Federal Circuit found ROM's device operated in a manner that did not utilize substantially the same structural components as described in Armaid's patent specification for the claimed function.

Practical Implications (6)

Q: How does Range of Motion Products, LLC v. Armaid Company Inc. affect me?

This decision reinforces the importance of precise claim drafting and the limitations imposed by means-plus-function claims. It clarifies that even if an accused product performs a similar function, it will not be found to infringe if its underlying structure is not substantially the same as that disclosed in the patent specification. As a decision from a federal appellate court, its reach is national. This case is moderate in legal complexity to understand.

Q: How does this ruling impact other companies making similar therapeutic devices?

Companies developing therapeutic devices must carefully analyze their product's structure in relation to the specific structures disclosed in existing patents, especially those with means-plus-function claims. Minor structural differences that alter the device's operation can lead to a finding of non-infringement.

Q: What should a patent holder like Armaid Company do after this ruling?

Armaid Company, as the patent holder, might consider re-evaluating its patent strategy, potentially focusing on enforcing patents with clearer structural limitations or exploring licensing opportunities. They may also need to be more precise in drafting future patent claims.

Q: What is the practical implication for Range of Motion Products, LLC?

For Range of Motion Products, LLC, the practical implication is that they have successfully defended against an infringement claim based on their current product. This allows them to continue selling their device without owing damages for infringement of Armaid's patent.

Q: Could ROM's product be found to infringe a different patent held by Armaid?

This specific ruling only addresses the alleged infringement of the particular patent at issue in this lawsuit. Armaid Company might hold other patents, and ROM's products could potentially infringe those, but that would require separate legal action and analysis.

Q: What are the potential consequences if ROM had been found to infringe?

If ROM had been found to infringe, the consequences could have included an injunction preventing them from selling their product, and they would likely have been liable for damages to Armaid Company, potentially including lost profits or a reasonable royalty.

Historical Context (3)

Q: How does this case fit into the broader landscape of patent litigation regarding means-plus-function claims?

This case reinforces the Federal Circuit's consistent approach to interpreting means-plus-function claims, emphasizing the importance of the structure disclosed in the patent specification. It highlights that even if an accused device performs a similar function, it will not be found to infringe if it lacks the equivalent structure.

Q: What legal precedent might have influenced the court's decision in Range of Motion Products v. Armaid Company Inc.?

The court's decision likely relied on established precedent regarding the interpretation of 35 U.S.C. § 112(f), particularly cases that have clarified the necessity of matching structure for means-plus-function claims. Decisions like *Enzo Biochem, Inc. v. Applera Corp.* or *In re Alappat* could provide foundational principles.

Q: Does this ruling set a new legal standard for therapeutic device patents?

No, this ruling does not set a new legal standard. Instead, it applies existing legal standards for interpreting 'means-plus-function' claims under 35 U.S.C. § 112(f), reinforcing the importance of structural equivalence as established in prior case law.

Procedural Questions (5)

Q: What was the docket number in Range of Motion Products, LLC v. Armaid Company Inc.?

The docket number for Range of Motion Products, LLC v. Armaid Company Inc. is 23-2427. This identifier is used to track the case through the court system.

Q: Can Range of Motion Products, LLC v. Armaid Company Inc. be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: How did the case reach the Federal Circuit?

The case reached the Federal Circuit on appeal from a district court's decision. Typically, patent infringement cases are first heard in federal district courts, and if a party is dissatisfied with the outcome, they can appeal to the Federal Circuit, which has exclusive jurisdiction over patent appeals.

Q: What was the district court's initial ruling that the Federal Circuit reviewed?

The district court initially found that Range of Motion Products, LLC did not infringe on Armaid Company Inc.'s patent. The Federal Circuit reviewed this decision to determine if it was legally correct.

Q: What does 'affirming' a district court's decision mean in this context?

Affirming means the Federal Circuit agreed with the district court's conclusion. In this case, the Federal Circuit agreed that ROM's product did not infringe Armaid's patent, upholding the lower court's judgment.

Cited Precedents

This opinion references the following precedent cases:

  • In re Donaldson Co., 16 F.3d 1189 (Fed. Cir. 1994)
  • Enzo Biochem, Inc. v. Applera Corp., 599 F.3d 1325 (Fed. Cir. 2010)

Case Details

Case NameRange of Motion Products, LLC v. Armaid Company Inc.
Citation
CourtFederal Circuit
Date Filed2026-02-02
Docket Number23-2427
Precedential StatusPublished
OutcomeDefendant Win
Dispositionaffirmed
Impact Score20 / 100
SignificanceThis decision reinforces the importance of precise claim drafting and the limitations imposed by means-plus-function claims. It clarifies that even if an accused product performs a similar function, it will not be found to infringe if its underlying structure is not substantially the same as that disclosed in the patent specification.
Complexitymoderate
Legal TopicsPatent infringement, Means-plus-function claims, Claim construction, 35 U.S.C. § 112(f), Structural equivalents in patent law
Jurisdictionfederal

Related Legal Resources

Federal Circuit Opinions Patent infringementMeans-plus-function claimsClaim construction35 U.S.C. § 112(f)Structural equivalents in patent law federal Jurisdiction Know Your Rights: Patent infringementKnow Your Rights: Means-plus-function claimsKnow Your Rights: Claim construction Home Search Cases Is It Legal? 2026 Cases All Courts All Topics States Rankings Patent infringement GuideMeans-plus-function claims Guide Doctrine of equivalents (Legal Term)Interpretation of means-plus-function claims (Legal Term)Substantiality of structural differences (Legal Term) Patent infringement Topic HubMeans-plus-function claims Topic HubClaim construction Topic Hub

About This Analysis

This comprehensive multi-pass AI-generated analysis of Range of Motion Products, LLC v. Armaid Company Inc. was produced by CaseLawBrief to help legal professionals, researchers, students, and the general public understand this court opinion in plain English. This case received our HEAVY-tier enrichment with 5 AI analysis passes covering core analysis, deep legal structure, comprehensive FAQ, multi-audience summaries, and cross-case practical intelligence.

CaseLawBrief aggregates court opinions from CourtListener, a project of the Free Law Project, and enriches them with AI-powered analysis. Our goal is to make the law more accessible and understandable to everyone, regardless of their legal background.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Related Cases

Other opinions on Patent infringement or from the Federal Circuit: